Ahluwalia MS, Ozair A, Drappatz J, Ye X, et al. Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clin Cancer Res 2024 Jun 5. doi: 10.1158/1078-0432.CCR-23-4098.
PMID: 38836759